MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 81 to 100 of 166,322 approvalsPage 5 of 8317

Diclofenac Diethylamine Emulgel

Approval Number: 国药准字H20254434
Registration: Jun 3, 2025

Timolol Maleate Eye Drops

Approval Number: 国药准字H20254418
Registration: Jun 3, 2025

Polymyxini B Sulphas for Injection

Approval Number: 国药准字H20254404
Registration: Jun 3, 2025

Minoxidil Liniment

Approval Number: 国药准字H20254406
Registration: Jun 3, 2025

Telmisartan and Amlodipine Tablets (Ⅱ)

Approval Number: 国药准字H20254435
Registration: Jun 3, 2025

Bumetanide Injection

Approval Number: 国药准字H20254456
Registration: Jun 3, 2025

Tedizolid Phosphate Tablets

Approval Number: 国药准字H20254436
Registration: Jun 3, 2025

Trazodone Hydrochloride Tablets

Approval Number: 国药准字H20254458
Registration: Jun 3, 2025

Oxacillin Sodium for Injection

Approval Number: 国药准字H20254447
Registration: Jun 3, 2025

Formoterol fumarate Inhalation Solution

Approval Number: 国药准字H20254433
Registration: Jun 3, 2025

Carbazochrome Sodium Sulfonate Injection

Approval Number: 国药准字H20254455
Registration: Jun 3, 2025

Ibuprofen Suspension

Approval Number: 国药准字H20254439
Registration: Jun 3, 2025

Potassium Chloride Granules

Approval Number: 国药准字H20254413
Registration: Jun 3, 2025

Hydrotalcite Suspension

Approval Number: 国药准字H20254454
Registration: Jun 3, 2025

Carbazochrome Sodium Sulfonate Tablets

Approval Number: 国药准字H20254419
Registration: Jun 3, 2025

Oxacillin Sodium for Injection

Approval Number: 国药准字H20254449
Registration: Jun 3, 2025

Oxacillin Sodium for Injection

Approval Number: 国药准字H20254448
Registration: Jun 3, 2025

Trazodone Hydrochloride Tablets

Approval Number: 国药准字H20254459
Registration: Jun 3, 2025

Sevoflurane for Inhalation

Approval Number: 国药准字HJ20250066
Registration: Jun 3, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.